News

AliveDx Suisse S.A. and Kyungil Hi-tec INC have signed an exclusive distribution agreement, which will enable Kyungil Hi-tec to distribute the MosaiQ® solution in South Korea. The distribution agreement takes effect immediately. This strategic partnership with an important partner in South Korea reaffirms AliveDx’s commitment to expanding its geographical presence and creating clinical and economical…

AliveDx Suisse S.A. and PZ Cormay S.A. have signed a distribution agreement, which will enable PZ Cormay to distribute the MosaiQ® solution in Poland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and presence across various regions and to creating clinical and economical value for clinicians, helping them to shorten…

We are excited to announce our participation in the upcoming ADLM 2024 Congress, from July 30 to August 1, 2024, in Chicago, USA. Visit us at booth #4055 to learn more about our high-quality blood bank reagents, and the latest advancements in our turnkey, fully automated autoimmune diagnostic solutions. If you wish to engage in…

AliveDx Suisse S.A. and Prolab IVD S.R.L. have signed a distribution agreement, which will enable Prolab to distribute the MosaiQ® solution in Romania. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to clinicians, aiding in faster diagnosis. This collaboration will allow…

AliveDx Suisse S.A. and BioAnalytica S.A. have signed a distribution agreement, which will enable BioAnalytica to distribute the MosaiQ® solution in Greece and Cyprus. The distribution agreement takes effect immediately. This strategic partnership underscores AliveDx’s commitment to expanding its geographical reach and creating clinical and economical value for clinicians, aiding them in reducing diagnosis time.…

AliveDx Suisse S.A. and Axon Lab AG have signed a distribution agreement, which will enable Axon Lab to distribute the MosaiQ® solution in Austria, Germany and Switzerland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and presence across various regions and to creating clinical and economical value for clinicians, helping…

AliveDx recently partnered with the Great Place To Work organization to support our journey toward becoming an exceptional workplace for all our employees. Our goal is to foster a sense of belonging, instill pride in the work we do, and create an environment where everyone is excited to come to work each day, united in…

We are excited to announce that two AliveDx abstracts are now available publicly in the Abstract Book of the European Congress of Rheumatology (EULAR 2024), an international event that will take place in Vienna, Austria from 12-15 June 2024. The first abstract provides an overview of the performance of the MosaiQ® AiPlex CTD solution, a…

We are pleased to announce that our Eysins site in Switzerland has successfully passed the annual ISO 14001 Surveillance Audit. This site, first certified in 2022, continues to demonstrate our commitment to environmental management and sustainability. The ISO 14001 is an internationally recognized standard for environmental management systems (EMS). This certification reaffirms the Eysins site’s…

AliveDx Suisse S.A. and Palex Medical S.A.U. have signed a distribution agreement, which will enable Palex to distribute the MosaiQ® solution in Spain. The distribution agreement takes effect immediately. This partnership reaffirms AliveDx’s commitment to expanding its geographical presence and creating clinical and economical value for clinicians, helping them to shorten the time to diagnosis.…